Evaluation of the Stinging Potential in Human Eyes
NCT02872207 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2018-12-12
Summary
The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.
Conditions
- Sunscreen Agents
Interventions
- DRUG
-
BAY 987516 (Y65-122)
5 µL in one eye
- DRUG
-
BAY 987516 (Y65-118)
5 µL in one eye
- DRUG
-
Control
5 uL in other eye
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-02-21
- Primary Completion
- 2015-02-22
- Completion
- 2015-02-22
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Irritation Potential of Products in Human Eyes
NCT02714166 ·Status: COMPLETED ·Phase: NA
-
Short-term Effects on Tear Film (Baby Shampoo vs Blephasol)
NCT04858113 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
Study Evaluating Safety of BT01001 Ophthalmic Solution
NCT07313722 ·Status: RECRUITING ·Phase: PHASE1
-
A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
NCT04633213 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02831387 ·Status: TERMINATED ·Phase: PHASE2
-
Blephacura Versus Baby Shampoo to Treat Blepharitis
NCT01115192 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
NCT02597803 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults
NCT05969236 ·Status: COMPLETED ·Phase: PHASE1
-
0.01% Hypochlorous Acid in the Treatment of Blepharitis
NCT05608980 ·Status: UNKNOWN ·Phase: NA
-
Systemic Pharmacokinetics of BOL-303224-A
NCT00407589 ·Status: COMPLETED ·Phase: PHASE1
-
Lid Wipes Versus Baby Shampoo in Patients With Seborrehic Blepharitis
NCT04441528 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome
NCT03162783 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of a Moisturizing Product on Dry Eye and Skin
NCT02683382 ·Status: COMPLETED ·Phase: NA
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT00622037 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
NCT07217678 ·Status: RECRUITING ·Phase: PHASE4
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers
NCT06978244 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
NCT04092907 ·Status: COMPLETED ·Phase: PHASE2
-
Ocular Comfort and Inflammation in Lid Hygiene Therapy
NCT02938078 ·Status: TERMINATED ·Phase: NA
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
NCT00423007 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT02242032 ·Status: COMPLETED ·Phase: PHASE1